HCA Healthcare Inc (NYSE:HCA) SVP Deborah M. Reiner Sells 2,050 Shares

HCA Healthcare Inc (NYSE:HCA) SVP Deborah M. Reiner sold 2,050 shares of the firm’s stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $150.12, for a total transaction of $307,746.00. Following the transaction, the senior vice president now owns 5,484 shares in the company, valued at approximately $823,258.08. The transaction was disclosed in a document filed with the SEC, which is available at this link.

NYSE:HCA traded down $1.31 during midday trading on Friday, reaching $149.57. The stock had a trading volume of 1,821,598 shares, compared to its average volume of 1,525,206. HCA Healthcare Inc has a 1-year low of $110.31 and a 1-year high of $151.97. The firm’s fifty day simple moving average is $146.75 and its 200-day simple moving average is $134.29. The stock has a market capitalization of $51.00 billion, a P/E ratio of 14.85, a PEG ratio of 1.18 and a beta of 0.93.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 28th. The company reported $3.09 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $3.09. HCA Healthcare had a net margin of 6.83% and a negative return on equity of 242.04%. The business had revenue of $13.52 billion for the quarter, compared to analyst estimates of $13.37 billion. During the same period last year, the business posted $3.01 EPS. HCA Healthcare’s revenue was up 10.2% compared to the same quarter last year. As a group, equities research analysts expect that HCA Healthcare Inc will post 11.68 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Monday, March 2nd will be paid a $0.43 dividend. The ex-dividend date of this dividend is Friday, February 28th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.40. This represents a $1.72 dividend on an annualized basis and a yield of 1.15%. HCA Healthcare’s dividend payout ratio (DPR) is presently 15.24%.

A number of large investors have recently bought and sold shares of the stock. NEXT Financial Group Inc lifted its holdings in HCA Healthcare by 17.9% during the 4th quarter. NEXT Financial Group Inc now owns 500 shares of the company’s stock valued at $74,000 after purchasing an additional 76 shares during the last quarter. Cibc Bank USA lifted its holdings in HCA Healthcare by 1.4% during the 4th quarter. Cibc Bank USA now owns 5,734 shares of the company’s stock valued at $848,000 after purchasing an additional 78 shares during the last quarter. Quadrant Capital Group LLC raised its stake in shares of HCA Healthcare by 7.5% in the fourth quarter. Quadrant Capital Group LLC now owns 1,311 shares of the company’s stock worth $178,000 after acquiring an additional 92 shares during the last quarter. Steward Partners Investment Advisory LLC raised its stake in shares of HCA Healthcare by 2.4% in the third quarter. Steward Partners Investment Advisory LLC now owns 4,034 shares of the company’s stock worth $485,000 after acquiring an additional 94 shares during the last quarter. Finally, Penserra Capital Management LLC raised its stake in shares of HCA Healthcare by 50.8% in the fourth quarter. Penserra Capital Management LLC now owns 294 shares of the company’s stock worth $41,000 after acquiring an additional 99 shares during the last quarter. Institutional investors and hedge funds own 69.54% of the company’s stock.

A number of research analysts have recently weighed in on the stock. Citigroup raised their price target on shares of HCA Healthcare from $156.00 to $168.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Bank of America upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating in a report on Friday, December 6th. Goldman Sachs Group restated a “buy” rating and set a $165.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Royal Bank of Canada raised their target price on shares of HCA Healthcare from $170.00 to $173.00 and gave the company an “outperform” rating in a research note on Wednesday, January 29th. Finally, Credit Suisse Group raised their target price on shares of HCA Healthcare from $169.00 to $173.00 and gave the company an “outperform” rating in a research note on Wednesday, January 29th. Two research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $163.81.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: What member countries make up the G-20?

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.